DIA 2023: Tamei Elliott Discusses Changes to the Role of Diversity in Clinical Trials

Session provides insight as to how to boost interoperability and expand the middleware on a global scale.

Panel discusses the advantages that these models can provide in adding efficiencies to the clinical trial process.

According to the session panelists, tackling challenges and finding efficiencies is imperative for success.

The presentation expresses the importance of putting the patient at the center of patient recruitment.

Session reveals how organizations can implement DCTs into their clinical trial planning and execution processes.

Breakout session discusses the impact of incorporating decentralized elements into oncology clinical trials on data integrity, patient safety, and regulatory approvals.